Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis

被引：0
|
作者：
H Schmeling
G Horneff
机构：
[1] Hospital for Sick Children,
[2] Asklepios Klinik,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Public Health; Adverse Event; Arthritis; Tumour Necrosis; Tumour Necrosis Factor;
D O I：
10.1186/1546-0096-6-S1-P41
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors
    Mease, PJ
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (04) : 298 - 304
  • [42] Tumour necrosis factor alpha (TNFα) single nucleotide polymorphisms (SNPs) in the idiopathic inflammatory myopathies (IIMs)
    Chinoy, H
    Salway, F
    John, S
    Ollier, WE
    Cooper, RG
    RHEUMATOLOGY, 2005, 44 : I43 - I43
  • [43] Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (06): : 516 - +
  • [44] Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis
    Swierkot, Jerzy
    Bogunia-Kubik, Katarzyna
    Nowak, Beata
    Bialowas, Katarzyna
    Korman, Lucyna
    Gebura, Katarzyna
    Kolossa, Katarzyna
    Jeka, Slawomir
    Wiland, Piotr
    JOINT BONE SPINE, 2015, 82 (02) : 94 - 99
  • [45] Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register
    Anink, Janneke
    Otten, Marieke H.
    Prince, Femke H. M.
    Hoppenreijs, Esther P. A. H.
    Wulffraat, Nico M.
    Swart, Joost F.
    ten Cate, Rebecca
    van Rossum, Marion A. J.
    van den Berg, J. Merlijn
    Dolman, Koert M.
    Koopman-Keemink, Yvonne
    Armbrust, Wineke
    Kamphuis, Sylvia
    van Pelt, Philomine A.
    Gorter, Simone L.
    van Suijlekom-Smit, Lisette W. A.
    RHEUMATOLOGY, 2013, 52 (04) : 712 - 717
  • [46] Pneumococcal vaccine in patients with idiopathic juvenile arthritis in treatment with tumor necrosis factor inhibitors
    Berho, Javiera
    Monsalvez, Maria-Paulina
    Rojas, Jorge
    Inostroza, Jaime
    Quezada, Arnoldo
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2021, 49 (04) : 149 - 154
  • [47] Genotoxicity of Anti-Tumor Necrosis Factor Therapy in Patients With Juvenile Idiopathic Arthritis
    Demirkaya, Erkan
    Cok, Ismet
    Durmaz, Emre
    Ulutas, Onur K.
    Ayaz, Nuray Aktay
    Besbas, Nesrin
    Ozen, Seza
    ARTHRITIS CARE & RESEARCH, 2010, 62 (01) : 73 - 77
  • [48] Association of tumour necrosis factor-alpha G/A-238 and G/A-308 single nucleotide polymorphisms with juvenile idiopathic arthritis
    Maddah, M.
    Harsini, S.
    Ziaee, V.
    Moradinejad, M. H.
    Rezaei, A.
    Zoghi, S.
    Sadr, M.
    Aghighi, Y.
    Rezaei, N.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2016, 43 (06) : 391 - 396
  • [49] Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis
    Kahn, Robin
    Berthold, Elisabet
    Gullstrand, Birgitta
    Schmidt, Tobias
    Kahn, Fredrik
    Geborek, Pierre
    Saxne, Tore
    Bengtsson, Anders A.
    Mansson, Bengt
    ACTA PAEDIATRICA, 2016, 105 (04) : 427 - 432
  • [50] Systematic review of clinical trials on the treatment of rheumatoid arthritis with tumour necrosis factor alpha (TNFα) inhibitors
    Reneses, S
    Pestana, L
    MEDICINA CLINICA, 2001, 116 (16): : 620 - 628
12345